НовостиBenzingaBeOne Medicines Raises FY2026 Sales Guidance from $6.600B-$6.800B to $6.900B-$7.000B vs $6.763B Est BeOne Medicines Raises FY2026 Sales Guidance from $6.600B-$6.800B to $6.900B-$7.000B vs $6.763B Est Benzinga 2026.11.05 11:03 (GMT+0) Открыть на Benzinga Другие новости